ArticleDermatology and therapy2026
Metabolic and Psychiatric Comorbidities in Dissecting Cellulitis of the Scalp: A Retrospective Cohort Study and Scoping Review.
Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDissecting cellulitis of the scalp (DCS) is a chronic inflammatory disorder traditionally described as affecting young Black men; however, its broader epidemiology and comorbidity profile remain incompletely characterized. We aimed to evaluate demographic characteristics and systemic comorbidities associated with DCS.
methodsWe performed a retrospective cohort study of patients diagnosed with DCS across the Mass General Brigham network from 1 January 2015 to 1 February 2025. Demographic characteristics and comorbidities, including metabolic, psychiatric, autoimmune, and smoking history, were extracted. In parallel, a structured scoping review of PubMed was performed to identify cohort studies reporting demographic and clinical data in DCS.
resultsTwenty-nine patients met inclusion criteria (89.7% male; mean age 35.9 ± 10.2 years), with diverse racial representation. Nearly half had at least one additional disorder on the follicular occlusion spectrum, and 82.8% had at least one metabolic dysfunction-associated comorbidity. Psychiatric diagnoses were present in 41.4% of patients. Seventeen published cohorts comprising 710 patients were identified. Across studies, DCS consistently demonstrated strong male predominance and heterogeneous racial distribution. Overweight or obese body mass index and metabolic comorbidities were frequently reported, while psychiatric comorbidity was underreported.
conclusionsThese findings challenge the conventional characterization of DCS as a disorder primarily of Black men and instead emphasize global heterogeneity. We instead support an association of DCS with male sex, metabolic dysfunction associated comorbidities, and psychiatric comorbidities. Limitations include the retrospective design, small institutional sample size, absence of control group, use of a single database, and heterogeneity in reporting across published cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.